Table 4.

Discharge outcomes for those survived during the index admission

	First cohort			Second cohort
Variable	Non-Steroid*	Steroid*	P‡	Non-IVIG	IVIG	P‡
Number of patients	181	91	–	168	84	–
VT/VF—no. (%)	2 (1.1)	0 (0.0)	–	0 (0.0)	0 (0.0)	–
High-grade AVB—no. (%)	1 (0.6)	0 (0.0)	–	0 (0.0)	0 (0.0)	–
Cardiac arrest—no. (%)	0 (0.0)	1 (1.1)	–	0 (0.0)	0 (0.0)	–
Heart failure—no. (%)	14 (7.7)	8 (8.8)	0.891	6 (3.6)	2 (2.4)	0.581
Heart transplantation—no. (%)	0 (0.0)	0 (0.0)	–	0 (0.0)	0 (0.0)	–
Any dialysis—no. (%)	0 (0.0)	0 (0.0)	–	0 (0.0)	0 (0.0)	–
New occurrence of dialysis	0 (0.0)	0 (0.0)	–	0 (0.0)	0 (0.0)	–
All-cause mortality	16 (8.8)	9 (9.9)	0.919	8 (4.8)	0 (0.0)	–
CV death	8 (4.4)	4 (4.4)	0.871	4 (2.4)	0 (0.0)	–

‡ Adjusted for propensity score (Cox regression);

*Steroid: those patients received high-dose steroid therapy; non-steroid: those patients without receiving high-dose steroid therapy

Abbreviations: AVB atrioventricular block, CV cardiovascular, IVIG intravenous immunoglobulin, VT ventricular tachycardia, VF ventricular fibrillation